Page 390 - First Aid for the USMLE Step 1 2020, Thirtieth edition [MedicalBooksVN.com]_Neat
P. 390

346        SEcTion iii    EndocrinE  ` endocrine—PAthology                                                                                                                  EndocrinE  ` endocrine—PAthology





               Diabetes mellitus
                AcUte mAniFestAtions  Polydipsia, polyuria, polyphagia, weight loss, DKA (type 1), hyperosmolar hyperglycemic state
                                      (type 2).
                                     Rarely, can be caused by unopposed secretion of GH and epinephrine. Also seen in patients on
                                      glucocorticoid therapy (steroid diabetes).
                chronic comPlicAtions  Nonenzymatic glycation:
                                         ƒ Small vessel disease (diffuse thickening of basement membrane) Ž retinopathy (hemorrhage,
                                        exudates, microaneurysms, vessel proliferation), glaucoma, nephropathy. Nodular
                                        glomerulosclerosis Ž progressive proteinuria (initially microalbuminuria; ACE inhibitors
                                        and ARBs are renoprotective) and arteriolosclerosis (causing hypertension) Ž chronic kidney
                                        disease.
                                         ƒ Large vessel atherosclerosis, CAD, peripheral vascular occlusive disease, gangrene Ž limb loss,
                                        cerebrovascular disease. MI most common cause of death.
                                     Osmotic damage (sorbitol accumulation in organs with aldose reductase and  or absent sorbitol
                                       dehydrogenase):
                                         ƒ Neuropathy (motor, sensory [glove and stocking distribution], and autonomic degeneration).
                                         ƒ Cataracts.
                diAgnosis            test                            diAgnostic cUtoFF    notes
                                     HbA 1c                          ≥ 6.5%               Reflects average blood glucose
                                                                                              over prior 3 months
                                     Fasting plasma glucose          ≥ 126 mg/dL          Fasting for > 8 hours
                                     2-hour oral glucose tolerance test   ≥ 200 mg/dL     2 hours after consumption of 75 g
                                                                                              of glucose in water
                                                 Insulin deficiency or severe insulin insensitivity

                    tissue glucose      ↑ glycogenolysis     ↑ gluconeogenesis      ↑ proteolysis         ↑ lipolysis
                    ↑
                      uptake

                                         Hyperglycemia,                             ↓ muscle mass,         ↑ plasma
                                           glycosuria                                weight loss          free fatty acids




                            ↑ plasma osmolality     Osmotic diuresis


                                                     Loss of water,                                      ↑ ketogenesis,
                               ↑ thirst                +    +                         Vomiting
                                                      Na , and K                                       ketonemia, ketonuria
                                                                                   Hyperventilation,      Anion gap
                                                     Hypovolemia
                                                                                  Kussmaul respiration  metabolic acidosis

                                                   Circulation failure,
                                                   ↓ tissue perfusion              ↑ serum lactate


                                                     Coma/death


















          FAS1_2019_08-Endocrine.indd   346                                                                             11/7/19   4:30 PM
   385   386   387   388   389   390   391   392   393   394   395